The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer

This study is ongoing, but not recruiting participants.
Information provided by H. Lee Moffitt Cancer Center and Research Institute

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Carcinoma, Non-Small-Cell Lung
2		Additional conditions recognized in this trial
			Carcinoma
			Lung Neoplasms
			Pleural Effusion, Malignant
3		More general conditions related to this trial
			Lung Diseases
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms by Site
			Neoplasms, Glandular and Epithelial
			Pleural Diseases
			Pleural Effusion
			Pleural Neoplasms
			Respiratory Tract Diseases
			Respiratory Tract Neoplasms
			Thoracic Neoplasms
4		Interventions listed in this trial
			Vinorelbine
			Docetaxel
			Gemcitabine
			Carboplatin
5		More general drug interventions related to this trial
			Anti-Infective Agents
			Antimetabolites
			Antimetabolites, Antineoplastic
			Antineoplastic Agents
			Antineoplastic Agents, Phytogenic
			Antiviral Agents
			Enzyme Inhibitors
			Immunologic Factors
			Immunosuppressive Agents
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Physiological Effects of Drugs
			Radiation-Sensitizing Agents
			Therapeutic Uses
6		Sponsors listed in this trial
			H. Lee Moffitt Cancer Center and Research Institute
			National Cancer Institute (NCI)
			Eli Lilly and Company
			Aventis Pharmaceuticals